Compare Intraco Penta Tbk. (INTA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intraco Penta Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Intraco Penta Tbk. trades at Rp61 (market cap 217.36B, 124.4K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Intraco Penta Tbk. is far larger — about 2.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INTA | SCPI | |
|---|---|---|
Market Cap | 217.36B | 104.4B |
Volume | 124.4K | — |
Lot | 1.24K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intraco Penta Tbk.
PT Intraco Penta Tbk (the Company) was established based on Notarial Deed No. 13 dated May 10, 1975 of Milly Karmila Sareal, S.H., notary in Jakarta. The company serves as agent for several heavy equipment manufacturer. The company is contracted for agency services by Baldwin manufacturing Company USA.
Read more on INTA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
